inThought offers market data, analysis and forecasting from a single source
BRIDGEWATER, N.J., June 29 /PRNewswire/ -- Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry, today introduced Wolters Kluwer Health inThought(TM), a new market research service that offers an array of pharmaceutical forecasting capabilities. inThought was developed to help financial analysts, health care suppliers and drug makers understand where developmental drugs, medical devices, and therapies are positioned today and where they are likely headed in the future.
inThought is among the first of a new generation of research services that can deliver data, analysis and forecasting from a single source, an approach that is both cost effective and helps streamline the market research process. inThought integrates Wolters Kluwer Health's trusted clinical, prescription, managed markets, and patient information -- recognized to be of the highest quality in the industry -- together with the keen insight and forecasting abilities developed by a team of highly skilled individuals including researchers, analysts and physicians.
"With research headcounts down, there's a fundamental shift in the way analysts and pharma customers want their research delivered," said Ben Weintraub, Director of Research, Wolters Kluwer Health inThought. "Rather than simply striving to offer more data faster, our approach sifts through the clutter to synthesize what is truly important."
Customers now have all of the tools they need from a single, independent source to aid them in making more efficient decisions about their products, markets and competitors. inThought's progressive approach benefits from the wealth of knowledge and experience provided by Wolters Kluwer Health Pharma Solutions' professional data analysts, a distinction that helps identify trends as they unfold.
"With inThought, we alleviate one of the main issues with traditional pharma research products: once you buy it, you still have to make time to use it and understand the implications for your product," said Mark Spiers, President and CEO, Wolters Kluwer Health, Pharma Solutions. "This approach provides an edge for understanding the future market for a pharmaceutical brand or medical device."
inThought research and analysis is available to customers through products such as research alerts geared toward specific customer requirements; subscriptions to a powerful, Web-based drug pipeline database that integrates inThought forecasts with detailed monitoring of drug development programs around the world; regular conference calls to connect customers with medical experts providing the physician perspective; revenue forecasts and probability of approval models for 300+ drugs in development; syndicated research reports that delve deep into specific markets; and custom research projects and counsel designed to meet individual customer needs.
For more information about Wolters Kluwer Health inThought, visit www.in-thought.com.
About Wolters Kluwer Health
Wolters Kluwer Health (Philadelphia, PA) is a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons(R); electronic information providers, such as Ovid, UpToDate(R), Medi-Span(R) and ProVation(R) Medical; and pharmaceutical information providers such as Adis International and Source(R).
Wolters Kluwer Health is a division of Wolters Kluwer, a leading global information services and publishing company. The company provides products and services for professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer had 2008 annual revenues of euro 3.4 billion ($4.9 billion), employs approximately 20,000 people worldwide, and maintains operations in over 35 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Visit www.wolterskluwer.com for information about our market positions, customers, brands, and organization.
Contact: Tom Kivett Kivett & Company Communications (212) 727-2935 email@example.com
|SOURCE Wolters Kluwer Health|
Copyright©2009 PR Newswire.
All rights reserved